Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1989-1-25
|
pubmed:abstractText |
To investigate the effect of partial correction of anemia in patients maintained by chronic intermittent hemodialysis on aerobic and anaerobic working capacity, eight patients underwent a bicycle spiro-ergometry before and after treatment with recombinant human erythropoietin (r-HuEPO). the initial mean (+/- SD) hemoglobin value was 5.9 mg/dl +/- 0.61 and increased during treatment to 10.9 +/- 0.59 mg/dl, P less than 0.0001). This partial correction of anemia resulted in a significant increase of both oxygen uptake at the anaerobic threshold and peak peripheral oxygen uptake at subjective exhaustion (P less than 0.01 and P less than 0.0002, respectively). The increase in oxygen uptake corresponded to significant increases in Watts, both at the anaerobic threshold and at maximum workload (P less than 0.02 and P less than 0.0004). These data show that partial correction of renal anemia results in a significant increase of both exercise capacity and maximum work.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0085-2538
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
525-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:3199672-Adult,
pubmed-meshheading:3199672-Anaerobiosis,
pubmed-meshheading:3199672-Anemia,
pubmed-meshheading:3199672-Erythropoietin,
pubmed-meshheading:3199672-Female,
pubmed-meshheading:3199672-Humans,
pubmed-meshheading:3199672-Male,
pubmed-meshheading:3199672-Middle Aged,
pubmed-meshheading:3199672-Oxygen Consumption,
pubmed-meshheading:3199672-Physical Exertion,
pubmed-meshheading:3199672-Recombinant Proteins,
pubmed-meshheading:3199672-Renal Dialysis
|
pubmed:year |
1988
|
pubmed:articleTitle |
Working capacity is increased following recombinant human erythropoietin treatment.
|
pubmed:affiliation |
2nd Department of Medicine, University of Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|